Cynosure Group LLC bought a new stake in Hawkins, Inc. (NASDAQ:HWKN - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,439 shares of the specialty chemicals company's stock, valued at approximately $299,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in Hawkins by 155.4% in the 4th quarter. Blue Trust Inc. now owns 355 shares of the specialty chemicals company's stock worth $44,000 after buying an additional 216 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in Hawkins by 262.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 442 shares of the specialty chemicals company's stock worth $55,000 after acquiring an additional 320 shares during the period. TD Private Client Wealth LLC grew its stake in shares of Hawkins by 242.5% in the third quarter. TD Private Client Wealth LLC now owns 459 shares of the specialty chemicals company's stock worth $59,000 after purchasing an additional 325 shares in the last quarter. KBC Group NV increased its holdings in shares of Hawkins by 37.0% during the fourth quarter. KBC Group NV now owns 948 shares of the specialty chemicals company's stock valued at $116,000 after purchasing an additional 256 shares during the period. Finally, Longboard Asset Management LP bought a new stake in shares of Hawkins during the fourth quarter valued at about $212,000. Institutional investors and hedge funds own 69.71% of the company's stock.
Analyst Upgrades and Downgrades
HWKN has been the subject of a number of recent analyst reports. CJS Securities began coverage on shares of Hawkins in a research report on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 target price for the company. BWS Financial reiterated a "neutral" rating and issued a $122.00 price objective on shares of Hawkins in a report on Friday, January 31st.
Read Our Latest Research Report on HWKN
Hawkins Price Performance
Shares of HWKN traded up $9.01 during midday trading on Wednesday, reaching $112.33. The stock had a trading volume of 141,209 shares, compared to its average volume of 123,927. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.50 and a quick ratio of 1.53. The company has a market capitalization of $2.35 billion, a P/E ratio of 28.66, a P/E/G ratio of 3.80 and a beta of 0.82. The firm's 50 day moving average price is $107.64 and its 200-day moving average price is $117.90. Hawkins, Inc. has a 52 week low of $71.98 and a 52 week high of $139.55.
Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing analysts' consensus estimates of $0.77 by ($0.05). Hawkins had a net margin of 8.60% and a return on equity of 18.95%. On average, analysts forecast that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.
Hawkins Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend was Friday, February 14th. Hawkins's payout ratio is 18.37%.
Hawkins Company Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Further Reading

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.